Tizanidine Tablet
Product Images NDC 80425-0500

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 80425-0500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine 2mg #30 (Tizanidine 2mg 80425 0500 01)

This text provides information about Tizanidine 2mg tablets, a medication comparable to Zanaflex. The tablets come in a pack of 30 and have a lot number and expiration date stamped on them. The tablets should be stored at 20°C to 25°C. The source NDC number and pharmacy details are also listed.*

FDA Label Image

Tizanidine 2mg #60 (Tizanidine 2mg 80425 0500 02)

FDA Label Image

Tizanidine 2mg #90 (Tizanidine 2mg 80425 0500 03)

This is a label for a package of Tizanidine 2mg tablets. It includes information such as the quantity (#90), manufacturer (Advancedr), comparing it to Zanaflex, and the expiration date (12/31/2026). The store temperature is recommended to be between 20°-26°C (66°-77°F). The product is sourced from NDC: 72578-0096-21, and the lot number is XX000KK. Located in Nashville, TN.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 01)

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 02)

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 03)

This text appears to provide information about the improvement in Ashworth Score over time post-dose for different interventions: 16 mg tizanidine, 8 mg tizanidine, and a placebo. The data likely indicates the effects of these treatments on the Ashworth Score at various intervals after administration.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 04)

This text mentions the improvement in Ashworth Score related to Tizanidine. The mean dose used was 26.8 mg and the evaluation was conducted at the end of titration, end of maintenance, and at the study endpoint (Last Observation Carried Forward). Further details on the study week and observations are mentioned for the evaluation of the Ashworth Score.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.